ARCHIVES

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

February 22, 1980

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995